Workflow for Performing Genetic Manipulation in Human Trophoblast Stem Cells Using CRISPR/Cas9 Technology

Hao Wu1,2,3,4, Yue Wang1,2,3,4, Hongmei Wang1,2,3,4

  • 1State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

Summary

We optimized CRISPR/Cas9 gene editing and transcriptional activation in human trophoblast stem cells (hTSCs) using a lentivirus method. This workflow enables efficient genetic modification and functional studies of placental development.